Cargando…
Treatment of Myasthenia Gravis Based on Its Immunopathogenesis
The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care medicine and symptomatic treatments. Its immunopathogenesis is fundamentally a T-cell-dependent autoimmune process resulting from loss of tolerance toward self-antigens in the thymus. Thymectomy is bas...
Autores principales: | Kim, Jee Young, Park, Kee Duk, Richman, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259491/ https://www.ncbi.nlm.nih.gov/pubmed/22259613 http://dx.doi.org/10.3988/jcn.2011.7.4.173 |
Ejemplares similares
-
Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
por: Wang, Zhen, et al.
Publicado: (2017) -
Muscle-Specific Kinase Myasthenia Gravis
por: Borges, Lucia S., et al.
Publicado: (2020) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007) -
Current Treatment of Myasthenia Gravis
por: Alhaidar, Mohammed K., et al.
Publicado: (2022) -
The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)